Smartphone App for Smoking Cessation
Trial Summary
What is the purpose of this trial?
This trial studies how well two smartphone apps, KickAsh and Breathe2Relax, help smokers with depressive symptoms quit smoking. KickAsh teaches relaxation skills, and Breathe2Relax improves mood and encourages fun activities. KickAsh combines methods from various approaches to help smokers quit.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if any medication could compromise your safety or treatment, the Principal Investigator may decide it's necessary.
What data supports the effectiveness of the treatment Smartphone Mobile Application for smoking cessation?
Is the smartphone app for smoking cessation safe to use?
How is the smartphone app for smoking cessation different from other treatments?
Research Team
Jennifer A. Minnix
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for English-speaking MD Anderson patients aged 18-65 who smoke daily, own an iOS device with regular app usage, and are willing to set a quit date within 30 days. They must have smoked for at least a year and either currently have or previously had depressive symptoms. People can't join if they're in another smoking cessation program or have health issues that make the study unsafe for them.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the KickAsh or Breathe2Relax smartphone mobile application designed to help with smoking cessation over 8 weeks
Follow-up
Participants are monitored for changes in activity level, mood, and smoking abstinence
Treatment Details
Interventions
- Smartphone Mobile Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator